Publisher： Karger
E-ISSN： 1424-0556|2|3|107-109
ISSN： 1422-9528
Source： Heart Drug, Vol.2, Iss.3, 2002-07, pp. : 107-109
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
The Increasingly Complex Fourth Hurdle for Pharmaceuticals
By Cohen Joshua Stolk Elly Niezen Maartje
PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. :
Access to resources
Recommend
Logistics of Primary Angioplasty
Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. :
Added angioplasty of no value in stable CAD
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
A Risk-Benefit Assessment of Abciximab in Angioplasty
By Kleiman N.S.
Drug Safety, Vol. 20, Iss. 1, 1999-01 ,pp. :
Prasugrel a promising antiplatelet agent for angioplasty
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :